[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2006109344A2 - Composition to be used for the treatment of parodontal pathologies - Google Patents

Composition to be used for the treatment of parodontal pathologies Download PDF

Info

Publication number
WO2006109344A2
WO2006109344A2 PCT/IT2006/000249 IT2006000249W WO2006109344A2 WO 2006109344 A2 WO2006109344 A2 WO 2006109344A2 IT 2006000249 W IT2006000249 W IT 2006000249W WO 2006109344 A2 WO2006109344 A2 WO 2006109344A2
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
propolis
calendula
gse
composition
Prior art date
Application number
PCT/IT2006/000249
Other languages
French (fr)
Other versions
WO2006109344A3 (en
Inventor
Andrea Monti
Original Assignee
Gasparini, Gianluigi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gasparini, Gianluigi filed Critical Gasparini, Gianluigi
Publication of WO2006109344A2 publication Critical patent/WO2006109344A2/en
Publication of WO2006109344A3 publication Critical patent/WO2006109344A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • composition to be used for the treatment of parodontal pathologies Composition to be used for the treatment of parodontal pathologies
  • the present invention relates to pharmaceutical products, particularly those for dentistry.
  • a composition is disclosed which is able to prepare products for use both in dentist's surgery and at home for the treatment and prevention of parodontal diseases .
  • Periodontium is the apparatus supporting a tooth and consists of gum, parodontal ligament, alveolar bone, and cement. Parodontal diseases or parodontal pathologies affect then the tooth supporting system and can cause a loosening and even the loss of the tooth as they progress.
  • the sparking factors are different: an insufficient dental cleaning with the consequence of bacterial dental plague and tartar deposit which causes processes of inflammation and mechanical irritations due to residual food deposit, dental traumas, anomalous tooth alignment, tooth filling or dental prosthesis. Further pathologies such as malnutrition, diabetes mellitus or blood pathologies or the prolonged use of some drugs can help the onset of diseases of the periodontium too.
  • the inventors of the present invention have set up a combination of natural extracts comprising propolis, ⁇ ncaria Tomentosa, Aloe Vera Barbadensis, Calendula, Vitamin K, Coenzyme QlO, vitamin ed extract of grapefruit seeds, the single functions of which are listed below.
  • Uncaria Tomentosa has antibacterial, antimycotic, decongestant, cicatrizant properties (Taylor L., Herbal Secrets of the Rainforest, 2nd ed. , Sage press, Inc. , 2002) .
  • Aloe Vera Barbadensis is a natural substance with antibacterial activity particularly to Stafilococco Aureo, Streptococcus Viridans, Streptococcus Mutans, Corynebacterium xerosis, antiviral, fungicidal activity (Candida Albicans), virucide activity (Herpes simplex and Herpes zoster) , anti-inflammatory activity, stabilizes and help the recovery of hurts and burns because of its easy penetration of the deepest epithelial layers.
  • Clinical studies comparing the anti-inflammatory effectiveness of Aloe Vera with prednisolone and indomethacin have found similar effects (Sims R. M., Zimmermann E. R., report of effect of Aloe Vera on growth of certain micro-organisms. Ava Inc. Archivies, 1:230-233, 1969).
  • Calendula is a vegetal antioxidant and a natural antiinflammatory.
  • Vitamin Kl is a specific anti-hemorrhagic agent.
  • Coenzyme QlO is a natural bearer of folic acid.
  • Vitamin C is astringent and antioxidant.
  • GSE extract of grapefruit seeds, has a natural marked antibiotic action over a wide germ spectrum such as: Staphylococcus, Streptococcus, Salmonella, Escherichia CoIi, Pseudomonas, Lactobacillus, Klebsiella , Shigella , Legionella pneumophila , Chlamidia, Helicobacter pylori, Herpes, Candida albicans, Aspergillus, Trocophyton and other fungus and ferments.
  • propolis is used as hydroalcoholic extract of propolis which is liquid and allows only a short- time application which is non-effective to develop the antibiotic, anti-inflammatory action at the gum groove.
  • Uncaria Tomentosa is typically used in the form of fluid extract which can stay in situ, i.e. the gum groove, only for a short time.
  • the composition which is the object of the present invention allows the single components to be available and active at the periodontium and at the same time their combination allows the therapeutic effectiveness to be increased synergistically .
  • the preparation of said composition by micro-encapsulation in non-phospholipidic vesicles allows a slower transdermic release of the active components and a greater stability of the latter.
  • a further embodiment of the invention consists of different formulations that can be used according to the parodontal disease to be faced.
  • the parodontal disease to be faced there is provided:
  • an object of the present invention is a composition that can be used for the preparation of a medicine for the treatment and prevention of parodontal pathologies having the following composition referred to 1000 g of product: Propolis 15-30 g
  • the composition also provides the addition of suitable excipients selected from the group consisting of: fructose, hydroxymethyl cellulose, glycerol, mint extract, and water.
  • suitable excipients selected from the group consisting of: fructose, hydroxymethyl cellulose, glycerol, mint extract, and water.
  • Mint extract 0, 5 g Water 884, 5 g

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A composition to be used for the treatment and the prevention of parodontal pathologies which is prepared by micro-encapsulation of slow release capsules.

Description

Composition to be used for the treatment of parodontal pathologies
The present invention relates to pharmaceutical products, particularly those for dentistry. A composition is disclosed which is able to prepare products for use both in dentist's surgery and at home for the treatment and prevention of parodontal diseases .
Periodontium is the apparatus supporting a tooth and consists of gum, parodontal ligament, alveolar bone, and cement. Parodontal diseases or parodontal pathologies affect then the tooth supporting system and can cause a loosening and even the loss of the tooth as they progress.
The sparking factors are different: an insufficient dental cleaning with the consequence of bacterial dental plague and tartar deposit which causes processes of inflammation and mechanical irritations due to residual food deposit, dental traumas, anomalous tooth alignment, tooth filling or dental prosthesis. Further pathologies such as malnutrition, diabetes mellitus or blood pathologies or the prolonged use of some drugs can help the onset of diseases of the periodontium too.
Therefore, the need for the preparation of pharmaceutical products that can be used for the treatment and prevention of parodontal diseases makes itself particularly felt.
The inventors of the present invention have set up a combination of natural extracts comprising propolis, ϋncaria Tomentosa, Aloe Vera Barbadensis, Calendula, Vitamin K, Coenzyme QlO, vitamin ed extract of grapefruit seeds, the single functions of which are listed below.
The effectiveness of propolis in the treatment of disease of the gum system is known at the state of art
(Monti A., Gasparini G., Zegarelli P. T., Battaglia G.
Attual. Odontostomatol. , XVIII, 3, 2002). Propolis is really effective as natural antibiotic.
Uncaria Tomentosa has antibacterial, antimycotic, decongestant, cicatrizant properties (Taylor L., Herbal Secrets of the Rainforest, 2nd ed. , Sage press, Inc. , 2002) .
Aloe Vera Barbadensis is a natural substance with antibacterial activity particularly to Stafilococco Aureo, Streptococcus Viridans, Streptococcus Mutans, Corynebacterium xerosis, antiviral, fungicidal activity (Candida Albicans), virucide activity (Herpes simplex and Herpes zoster) , anti-inflammatory activity, stabilizes and help the recovery of hurts and burns because of its easy penetration of the deepest epithelial layers. Clinical studies comparing the anti-inflammatory effectiveness of Aloe Vera with prednisolone and indomethacin have found similar effects (Sims R. M., Zimmermann E. R., report of effect of Aloe Vera on growth of certain micro-organisms. Ava Inc. Archivies, 1:230-233, 1969).
Calendula is a vegetal antioxidant and a natural antiinflammatory. Vitamin Kl is a specific anti-hemorrhagic agent. Coenzyme QlO is a natural bearer of folic acid. Vitamin C is astringent and antioxidant. GSE, extract of grapefruit seeds, has a natural marked antibiotic action over a wide germ spectrum such as: Staphylococcus, Streptococcus, Salmonella, Escherichia CoIi, Pseudomonas, Lactobacillus, Klebsiella , Shigella , Legionella pneumophila , Chlamidia, Helicobacter pylori, Herpes, Candida albicans, Aspergillus, Trocophyton and other fungus and ferments. Its action affects the cytoplasmic membrane of the micro-organisms where its proximate principles upset the structure thereof, thus preventing amino acids from being absorbed and inducing portions with low molecular weight to come out of the cells ("Grapefruit Seed Extract", Alt. Med. Dig. USA, 7, 1994) . Said proximate principles are not known in the form allowing them to be used in dentistry.
Typically, propolis is used as hydroalcoholic extract of propolis which is liquid and allows only a short- time application which is non-effective to develop the antibiotic, anti-inflammatory action at the gum groove.
Also Uncaria Tomentosa is typically used in the form of fluid extract which can stay in situ, i.e. the gum groove, only for a short time. Conversely, the composition which is the object of the present invention allows the single components to be available and active at the periodontium and at the same time their combination allows the therapeutic effectiveness to be increased synergistically . According to another advantageous feature, the preparation of said composition by micro-encapsulation in non-phospholipidic vesicles allows a slower transdermic release of the active components and a greater stability of the latter.
A further embodiment of the invention consists of different formulations that can be used according to the parodontal disease to be faced. In particular there is provided:
- a preparation provided for use in dentist' s surgery and to be used after parodontal treatments (tartar ablation, courettage above and under gums, parodontal interventions) ; - a preparation for use at home in prolonged treatments;
- a preparation to carry on the therapy through the daily dental care in the form of toothpaste or mouthwash. Therefore, an object of the present invention is a composition that can be used for the preparation of a medicine for the treatment and prevention of parodontal pathologies having the following composition referred to 1000 g of product: Propolis 15-30 g
Uncaria Tomentosa 5-10 g
Calendula 15-30 g
Aloe Vera 10-20 g
Vitamin C 1-5 g Vitamin Kl 5-10 g
Dry extract of GSE 15-30 g optionally added with coenzyme QlO 10-20 g. The composition also provides the addition of suitable excipients selected from the group consisting of: fructose, hydroxymethyl cellulose, glycerol, mint extract, and water. The single formulations for use both in dentist's surgery and at home are listed below as embodiments of the invention, all referred to 1000 g of product.
1. Formulation for use in dentist's surgery:
Propolis 30 g Uncaria Tomentosa 10 g
Calendula 30 g
Aloe Vera 20 g
Vitamin C 5 g
Coenzyme QlO 20 g Vitamin Kl 10 g
Dry extract of GSE 30 g
Fructose 20 g
Hydroxymethyl cellulose 18 g
Glycerol 80 g Mint extract 1 g
Water 726 g
2. Formulation for use at home in prolongjeΘdQ. tI Lrieead.tLmlLLecnt:
Propolis 15 g
Uncaria Tomentosa 5 g Calendula 15 g
Aloe Vera 10. g
Vitamin C 5 g
Vitamin Kl 10 g
Dry extract of GSE 15 g Fructose 10 g
Hydroxymethyl cellulose 18 g
Glycerol 80 g
Mint extract o, 5 g
Water 816, 5 g 3. Formulation for dental care in tthhee ffoorrmm of toothpaste :
Propolis 20 g Uncaria Tomentosa 10 g
Calendula 20 g
Aloe Vera 10 g
Vitamin C 5 g Coenzyme QlO 10 ' g
Vitamin Kl 10 g
Dry extract of GSE 20 g
Fructose 10 g
Hydroxymethyl cellulose 18 g Glycerol 80 g
Mint extract o, 5 g
Water 786, 5 g
4. Formulation for dental care in tthhee ffoorrmm of mouthpaste : Propolis 20 g
Uncaria Tomentosa 10 g
Calendula 20 g
Aloe Vera 10 g
Vitamin C 5 g Coenzyme QlO 10 g
Vitamin Kl 10 g
Dry extract of GSE 20 g
Fructose 10 g
Mint extract 0, 5 g Water 884, 5 g

Claims

Claims
1. A composition to be used to prepare a medicine for the treatment and the prevention of parodontal pathologies comprising in 1000 g of product:
Propolis 15-30 g Uncaria Tomentosa 5-10 g
Calendula 15-30 g
Aloe Vera 10-20 g
Vitamin C 1-5 g
Vitamin Kl 5-10 g Dry extract of GSE 15-30 g and suitable pharmacologically acceptable excipients .
2. The composition according to claim 1, further comprising 10 to 20 g coenzyme QlO.
3. The composition according to claim 1 for professional service in dentist's surgery having the following composition in 1000 g of product: Propolis 30 g
Uncaria Tomentosa 10 g
Calendula 30 g
Aloe Vera 20 g
Vitamin C 5 g Coenzyme QlO 2O g
Vitamin Kl 1O g
Dry extract of GSE 30 g
Fructose 20 g
Hydroxymethyl cellulose 18 g Glycerol 8O g
Mint extract 1 g
Water 726 g
4. The composition according to claim 1 for use at home in prolonged treatments having the following composition in 1000 g of product:
Propolis 15 g
Uncaria Tomentosa 5 g Calendula 15 g
Aloe Vera 10 g
Vitamin C 5 g
Vitamin Kl 1O g
Dry extract of GSE 15 g Fructose 10 g
Hydroxymethyl cellulose 18 g
Glycerol 80 g
Mint extract 0,5 g
Water 816,5 g
5. The composition according to claim 1 for dental care in the form of toothpaste having the following composition:
Propolis 20 g ϋncaria Tomentosa 10 g
Calendula " 20 g
Aloe Vera 10 g
Vitamin C 5 g
Coenzyme QlO 10 g Vitamin Kl 10 g
Dry extract of GSE 20 g
Fructose 10 g Hydroxymethyl cellulose 18 g
Glycerol 80 g
Mint extract 0,5 g
Water 786,5 g
6. The composition according to claim 1 for dental care in the form of mouthwash having the following composition:
Propolis 20 g Uncaria Tomentosa 10 g
Calendula 20 g
Aloe Vera 10 g
Vitamin C 5 g
Coenzyme QlO 10 g Vitamin Kl 10 g
Dry extract of GSE 20 g
Fructose 10 g
Mint extract 0,5 g
Water 884,5 g
7. The composition according to any preceding claim, characterized in that it is able to be prepared by micro-encapsulation in non-phospholipidic vesicles, thus providing a slower transdermic release of the active components and a greater stability of the latter.
PCT/IT2006/000249 2005-04-13 2006-04-13 Composition to be used for the treatment of parodontal pathologies WO2006109344A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000179A ITRM20050179A1 (en) 2005-04-13 2005-04-13 APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
ITRM2005A000179 2005-04-13

Publications (2)

Publication Number Publication Date
WO2006109344A2 true WO2006109344A2 (en) 2006-10-19
WO2006109344A3 WO2006109344A3 (en) 2007-05-03

Family

ID=36956086

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2006/000249 WO2006109344A2 (en) 2005-04-13 2006-04-13 Composition to be used for the treatment of parodontal pathologies

Country Status (2)

Country Link
IT (1) ITRM20050179A1 (en)
WO (1) WO2006109344A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074979A1 (en) * 2006-12-20 2008-06-26 Mars, Incorporated Oral health composition comprising uncaria tomentosa
FR2932386A1 (en) * 2008-06-17 2009-12-18 David Marcel Dohan Composition, comprises at least three original natural bioactive compounds e.g. Aloe vera, apricot kernel, rosehip and manuka, with additional ingredients e.g. zinc, iron and phosphorus
FR2932385A1 (en) * 2008-06-17 2009-12-18 David Marcel Dohan COMPOSITION COMPRISING MICROENCAPSULATED NATURAL EXTRACTS FOR ORAL OR MUCOSAL APPLICATION
EP2130545A3 (en) * 2008-06-02 2010-01-13 Thomas Dr. Tenspolde Solution and tincture
WO2012001337A1 (en) * 2010-07-01 2012-01-05 Robert Peter Taylor Composition for dental health
EP2808009A1 (en) * 2013-05-28 2014-12-03 Vitalgaia SAS Toothpaste comprising propolis extract
EP2954902A1 (en) * 2014-06-13 2015-12-16 Laurent Haddad Composition comprising grapefruit seed extract, alchemilla leaf extract, stevia extract and curcumin
CN105193686A (en) * 2015-09-16 2015-12-30 杭州蜂情科技有限公司 Female care solution and preparation method thereof
ES2578057R1 (en) * 2013-05-28 2016-09-27 Vitalgaia España, S.L. TOOTHPASTE THAT INCLUDES PROPOLIS EXTRACT
ITUA20163253A1 (en) * 2016-05-09 2017-11-09 Giacomo Bruzzesi UNCARIA TOMENTOSA FOR DENTAL USE

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336925A1 (en) * 1975-12-30 1977-07-29 Mouney Guy Dentifrice contg. haemostatic agent, esp. ascorbic acid or salt - has curative action on lesions of gingival epithelium etc.
US5294434A (en) * 1991-04-22 1994-03-15 King Ronald M Aloe vera gel toothpaste
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
RU2134098C1 (en) * 1996-08-14 1999-08-10 Кражан Ирина Алексеевна Method for treating inflammatory periodontium diseases
WO2002076433A1 (en) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Dental formulation
US20040265247A1 (en) * 2003-05-20 2004-12-30 Gc Corporation Mouth rinse composition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2336925A1 (en) * 1975-12-30 1977-07-29 Mouney Guy Dentifrice contg. haemostatic agent, esp. ascorbic acid or salt - has curative action on lesions of gingival epithelium etc.
US5294434A (en) * 1991-04-22 1994-03-15 King Ronald M Aloe vera gel toothpaste
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
RU2134098C1 (en) * 1996-08-14 1999-08-10 Кражан Ирина Алексеевна Method for treating inflammatory periodontium diseases
WO2002076433A1 (en) * 2001-03-27 2002-10-03 C.S. Bioscience, Inc. Dental formulation
US20040265247A1 (en) * 2003-05-20 2004-12-30 Gc Corporation Mouth rinse composition

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BOTUSHANOV P I ET AL: "A clinical study of a silicate toothpaste with extract from propolis." FOLIA MEDICA. 2001, vol. 43, no. 1-2, 2001, pages 28-30, XP009076930 ISSN: 0204-8043 *
GASIOROWSKA I ET AL: "[The use of Calendula officinalis in the treatment of periodontopathies]" CZASOPISMO STOMATOLOGICZNE. APR 1983, vol. 36, no. 4, April 1983 (1983-04), pages 307-311, XP009077055 ISSN: 0011-4553 *
GEBARA ELAINE C E ET AL: "Propolis antimicrobial activity against periodontopathic bacteria." BRAZILIAN JOURNAL OF MICROBIOLOGY, vol. 33, no. 4, 2002, pages 365-369, XP009076928 ISSN: 1517-8382 *
GEBARAA ELAINE CRISTINA ESCOBAR ET AL: "Propolis extract as an adjuvant to periodontal treatment." ORAL HEALTH & PREVENTIVE DENTISTRY. 2003, vol. 1, no. 1, 2003, pages 29-35, XP001248908 ISSN: 1602-1622 *
IAUK L ET AL: "Antibacterial activity of medicinal plant extracts against periodontopathic bacteria." PHYTOTHERAPY RESEARCH : PTR. JUN 2003, vol. 17, no. 6, June 2003 (2003-06), pages 599-604, XP002414677 ISSN: 0951-418X *
NAKAGAWA TANEAKI ET AL: "Clinical effects on gingivitis of a new dentifrice containing 3 percent propolis" SHIKWA GAKUHO, vol. 97, no. 6, 1997, pages 649-654, XP009076929 ISSN: 0037-3710 *
RIEGER LISA ET AL: "The clinical effects of saline and aloe vera rinses on periodontal surgical sites." JOURNAL - OKLAHOMA DENTAL ASSOCIATION. WINTER 2002, vol. 92, no. 3, January 2002 (2002-01), pages 40-43, XP009076931 ISSN: 0164-9442 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008074979A1 (en) * 2006-12-20 2008-06-26 Mars, Incorporated Oral health composition comprising uncaria tomentosa
EP2130545A3 (en) * 2008-06-02 2010-01-13 Thomas Dr. Tenspolde Solution and tincture
FR2932386A1 (en) * 2008-06-17 2009-12-18 David Marcel Dohan Composition, comprises at least three original natural bioactive compounds e.g. Aloe vera, apricot kernel, rosehip and manuka, with additional ingredients e.g. zinc, iron and phosphorus
FR2932385A1 (en) * 2008-06-17 2009-12-18 David Marcel Dohan COMPOSITION COMPRISING MICROENCAPSULATED NATURAL EXTRACTS FOR ORAL OR MUCOSAL APPLICATION
WO2009153419A1 (en) * 2008-06-17 2009-12-23 David Dohan Composition comprising natural microencapsulated extracts for oral, skin, or mucosa application
WO2012001337A1 (en) * 2010-07-01 2012-01-05 Robert Peter Taylor Composition for dental health
EP2808009A1 (en) * 2013-05-28 2014-12-03 Vitalgaia SAS Toothpaste comprising propolis extract
ES2578057R1 (en) * 2013-05-28 2016-09-27 Vitalgaia España, S.L. TOOTHPASTE THAT INCLUDES PROPOLIS EXTRACT
EP2954902A1 (en) * 2014-06-13 2015-12-16 Laurent Haddad Composition comprising grapefruit seed extract, alchemilla leaf extract, stevia extract and curcumin
US20150359835A1 (en) * 2014-06-13 2015-12-17 Laurent Haddad Composition of a medical device or cosmetic product based on grapefruit seed extract, lady's mantle leaf extract, stevia extract, and curcumin
FR3022140A1 (en) * 2014-06-13 2015-12-18 Laurent Haddad COMPOSITION OF A MEDICAL DEVICE OR COSMETIC PRODUCT BASED ON GRAPEFRUIT PEPIN EXTRACT, ALCHEMILLE FOIL EXTRACT, STEVIA EXTRACT AND CURCUMIN
CN105193686A (en) * 2015-09-16 2015-12-30 杭州蜂情科技有限公司 Female care solution and preparation method thereof
ITUA20163253A1 (en) * 2016-05-09 2017-11-09 Giacomo Bruzzesi UNCARIA TOMENTOSA FOR DENTAL USE

Also Published As

Publication number Publication date
ITRM20050179A1 (en) 2006-10-14
WO2006109344A3 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
WO2006109344A2 (en) Composition to be used for the treatment of parodontal pathologies
RU2450819C2 (en) Herbal compositions for treating oral diseases
CN101574445B (en) A Chinese medicinal composition for oral health
EP1444984B1 (en) Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes
US7829067B2 (en) Method and composition for treating oral bacteria and inflammation
US20120219621A1 (en) Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
RU2385709C2 (en) Oral care composition for prevention of dental deposit containing magnolia extract
EP3237069A1 (en) Oral care compositions
KR20190000955A (en) Composition for preventing or treating periodontal disease comprising extracts of herbal mixture
Anand Herbal therapy in periodontics: a review
Salman et al. Use of herbs and medicinal plants in dentistry: a review
WO2000056344A1 (en) Artificial saliva
HUE034519T2 (en) Tamarind seed polysaccharide and ferula hermonis extract for use in the treatment of inflammatory diseases
Ananthathavam et al. Treating periodontitis with the use of essential oil and herbs
US20240091143A1 (en) Semi-solid chewable compositions and methods of making and using thereof
CN104039327A (en) Composition Comprising Tauroursodeoxycholic Acid
CN117582465A (en) Orally disintegrating tablet based on oral antibacterial composition and preparation method thereof
US20240277003A1 (en) Chewable gel compositions with extended oral resident time and methods of making and using thereof
JP6315741B2 (en) Composition for oral cavity containing NSAIDs or heparins
Salma et al. Triphala: The mystical herb and its role in dentistry
Audrey et al. Evaluation of the anti-inflammatory activity of a gel based on Afzelia africana (fabaceae) leaves
Kanika Efficacious Evaluation of Aloe Vera Tooth Gel and Commercially Available Tooth Gel on Patients with Gingivitis
EP2441439A1 (en) Pharmacological aid for prevention of incipient carious lesion and dentinal hypersensibility
JP2007269805A (en) Artificial saliva
AU2007264709B2 (en) Herbal compositions for the treatment of diseases of the oral cavity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06745277

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6745277

Country of ref document: EP